UPClytics
EnglishDeutsch
Sign inSign up
View all cases

UPC CoA 446/2025

May 23, 2025·EP1830843 +1 more: INDOLIDONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

Case details
Status
Case Closed
Action
Appeal
Category
Main Appeal
Parties
Claimants
Reps: Joana Piriquito Santos (Piriquito Santos & Associados)
Respondents
Reps: Patrícia Paias (Antas da Cunha Ecija)
Division
Court of Appeal
Judges
Technology
Organic Chemistry
Language
English
Decisions
  • 2025-08-13
    PI grantedAppeal RoP220.1

    The Court of Appeal set aside the Lisbon Local Division's refusal to grant provisional measures and ordered a preliminary injunction against Zentiva Portugal prohibiting the making, offering, placing on the market or use of nintedanib products (Nintedanib Zentiva 100mg and 150mg soft capsules) for idiopathic pulmonary fibrosis in 17 UPC Contracting Member States while EP 1 830 843 remains in force. The court held that completion of national HTA/pricing/reimbursement procedures constitutes imminent infringement. Zentiva was ordered to pay EUR 199,000 as an interim award of costs. The request for an information order was denied.

    Legal issues:Imminent infringement in generic medicines contextMarketing authorisation vs HTA/pricing procedures as imminent infringementOrder to communicate information under Art. 67 UPCANational law as source of law under Art. 24 UPCAProvisional measures in pharmaceutical patent disputes
    Damages: 199,000
Documents
Document titleDatePublic
Acknowledgement-of-lodging2025-08-14Not public
Acknowledgement-of-lodging2025-08-14Not public
Headnote-and-Keywords2025-08-14Not public
DecisionOutcome2025-08-14Not public
Final order2025-08-14Public
Decision-On-Appeal-On-Measures-Outcome2025-08-13Not public
Final order2025-08-13Public
Hearing reference2025-07-23Not public
Hearing reference2025-07-23Not public
Receipt2025-07-21Not public
Exhibit 22025-07-19Not public
Application - new framework agreement2025-07-19Not public
Exhibit 12025-07-19Not public
Interim-Procedure-Closure2025-06-30Not public
Summon-Oral-Hearing2025-06-30Not public
Summons to OH2025-06-30Public
Interim-Conference-Decision2025-06-30Not public
Receipt2025-06-26Not public
Boehringer Statement of Response2025-06-25Not public
Generic application2025-06-25Not public
Boehringer Statement of Response2025-06-25Not public
Application in response to order re. OH 20.06.20252025-06-20Not public
Comments pursuant to RoP 2642025-06-20Not public
Receipt2025-06-20Not public
OH request follow up BI vs Zentiva2025-06-20Not public
OH request follow up BI vs Zentiva2025-06-20Not public
Response to the Order of the Court issued on 16 June 20252025-06-20Not public
Application in Response to CoA Order OH2025-06-20Not public
Request for OH availability2025-06-16Not public
Acknowledgement-of-lodging2025-06-12Not public
Panel-Appointment2025-06-12Not public
Receipt2025-06-12Not public
Acknowledgement-of-lodging2025-06-12Not public
Requirements-OK-Cross-Appeal2025-06-12Not public
Panel-Appointment2025-06-12Not public
Acknowledgement-of-lodging2025-06-11Not public
Exhibit 1 - Decision and Final Report under Framework Agreement - Part 12025-06-11Not public
Exhibit 1A - Payment of Court Fees2025-06-11Not public
Exhibit 1 - Decision and Final Report under Framework Agreement - Part 32025-06-11Not public
Exhibit 1 - Call for proposals under Framewrok Agreement - Part 12025-06-11Not public
Exhibit 1 - Decision and Final Report under Framework Agreement - Part 22025-06-11Not public
Exhibit 1 - Decision and Final Report under Framework Agreement - Part 52025-06-11Not public
Exhibit 1 - Call for proposals under Framework agreement - Part 22025-06-11Not public
Exhibit 1 - Call for proposals under Framework agreement - Part 32025-06-11Not public
Exhibit 1 - Decision and Final Report under Framework Agreement - Part 42025-06-11Not public
Statement and Grounds of Cross-appeal2025-06-11Not public
Exhibit 1 - Call for proposals under Framework Agreement - Part 42025-06-11Not public
Exhibit 1 - Generic application 08.04.20252025-06-11Not public
Exhibit 2 - Statement Onsynergy2025-06-11Not public
Acknowledgement-of-lodging2025-06-10Not public
Exhibit 1 - Part 42025-06-10Not public
Statement of Response | Cross-Appeal2025-06-10Not public
Exhibit 1 - Part 32025-06-10Not public
Exhibt 1- Part 12025-06-10Not public
Exhibit 1 - Part 72025-06-10Not public
Exhibit 1A2025-06-10Not public
Exhibit 1 - Part 82025-06-10Not public
Exhibit 1 - Part 102025-06-10Not public
Exhibit 1 - Part 62025-06-10Not public
Exhibit 1 - Part 22025-06-10Not public
Exhibit 1 - Part 92025-06-10Not public
Exhibit 22025-06-10Not public
Exhibit 1 - Part 52025-06-10Not public
Acknowledgement-of-lodging2025-05-26Not public
Panel-Appointment2025-05-26Not public
Receipt2025-05-26Not public
Formal-checks_Notification-of-positive-outcome2025-05-26Not public
Acknowledgement-of-lodging2025-05-23Not public
Exhibit 1A2025-05-23Not public
Statement of Appeal and Statement of Grounds of Appeal2025-05-23Not public
Exhibit 2A2025-05-23Not public